Cryo-Shocked Platelet Coupled with ROS-Responsive Nanomedicine for Targeted Treatment of Thromboembolic Disease
ACS Nano · 11.04.2023 · 17 (7) · 6519-6533
DOI: 10.1021/acsnano.2c11865 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 27.03.2023. Verfasst von Xingping Quan und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau, SAR 999078, C…. Hauptthemen laut MEDLINE: Thrombosis, Stroke. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Universidade de Macau, Shenzhen Science and Technology Innovation Commission.
Abstract (Originalsprache)
Thrombolysis with tissue plasminogen activator (tPA) provides the most common therapy for ischemic stroke onset within the past 4.5 h. However, enhanced neutrophil infiltration and secondary blood-brain barrier injury caused by tPA administration have limited its therapeutic application, and tPA treatment is often accompanied by hemorrhagic transformation. To overcome the limitations of thrombolysis by tPA, maximize the therapeutic efficacy, and improve the safety, herein, we report a cryo-shocked platelet-based cell-hitchhiking drug delivery system, which consists of cryo-shocked platelet (CsPLT) and reactive oxygen species (ROS)-responsive liposomes loaded with thrombolytic tPA and anti-inflammation drug aspirin (ASA). CsPLT and liposomes were facilely conjugated via host-guest interactions. Under the guidance of CsPLT, it selectively accumulated in the thrombus site and quickly released the therapeutic payloads in response to the high ROS. tPA subsequently exhibited localized thrombolytic activity to suppress the expansion of thrombus, while ASA assisted in the inactivation of reactive astrogliosis, microglial/macrophage, and obstruction of neutrophil infiltration. This cryo-shocked platelet-hitchhiking tPA/ASA delivery system not only improves the thrombus-targeting efficiency of the two drugs for highly localized thrombolytic effects and anti-inflammation actions and platelets inactivation but also provides insights to the development of targeted drug delivery systems for thromboembolic disease treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau, SAR 999078, China.
- Cancer Center, Faculty of Health Sciences, University of Macau, Taipa, Macau, SAR 999078, China.
- Department of Pharmaceutical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macau, SAR 999078, China.
ORCID-Profile: Xiao Liang, Zhen Yuan, Ruibing Wang, Yonghua Zhao
Förderung
- State Key Laboratory of Quality Research in Chinese Medicine, University of Macau
- Universidade de Macau
- Shenzhen Science and Technology Innovation Commission
- Fundo para o Desenvolvimento das Ci??ncias e da Tecnologia
- National Natural Science Foundation of China
Zitieren
APA
Quan, X., Liang, X., Ding, Y., Han, Y., Li, J., Yuan, M., Li, Y., Yuan, Z., Wang, R., & Zhao, Y. (2023). Cryo-Shocked Platelet Coupled with ROS-Responsive Nanomedicine for Targeted Treatment of Thromboembolic Disease. ACS Nano, 17(7), 6519-6533. https://doi.org/10.1021/acsnano.2c11865
Vancouver
Quan X, Liang X, Ding Y, Han Y, Li J, Yuan M, et al. Cryo-Shocked Platelet Coupled with ROS-Responsive Nanomedicine for Targeted Treatment of Thromboembolic Disease. ACS Nano. 2023;17(7):6519-6533. doi:10.1021/acsnano.2c11865
BibTeX
@article{Quan2023,
author = {Quan, Xingping and Liang, Xiao and Ding, Yuanfu and Han, Yan and Li, Junyan and Yuan, Mengchen and Li, Yiyang and Yuan, Zhen and Wang, Ruibing and Zhao, Yonghua},
title = {Cryo-Shocked Platelet Coupled with ROS-Responsive Nanomedicine for Targeted Treatment of Thromboembolic Disease},
journal = {ACS Nano},
year = {2023},
volume = {17},
number = {7},
pages = {6519--6533},
doi = {10.1021/acsnano.2c11865}
}
EUVIMED